HemaSphere (Aug 2023)

PB2372: PP2A INHIBITOR LB100 ENHANCES THE SENSITIVITY OF NPM-ALK+ALCL TO CRIZOTINIB AND REVERSES THE RESISTANCE OF ALCL TO CRIZOTINIB

Wenyu Shi

Affiliations

Wenyu Shi: 1 Affiliated Hospital of Nantong University, Department of Oncology, Nantong, China

DOI: https://doi.org/10.1097/01.HS9.0000976204.86062.c5
Journal volume & issue: Vol. 7
p. e86062c5

Abstract

No abstracts available.

Published in HemaSphere

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://onlinelibrary.wiley.com/journal/25729241

About the journal